These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 24290226
1. The prolongation of length of stay because of Clostridium difficile infection. Mitchell BG, Gardner A, Barnett AG, Hiller JE, Graves N. Am J Infect Control; 2014 Feb; 42(2):164-7. PubMed ID: 24290226 [Abstract] [Full Text] [Related]
4. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. Pakyz AL, Jawahar R, Wang Q, Harpe SE. J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619 [Abstract] [Full Text] [Related]
8. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship. Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE. Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522 [Abstract] [Full Text] [Related]
9. Length of stay and mortality due to Clostridium difficile infection acquired in the intensive care unit. Dodek PM, Norena M, Ayas NT, Romney M, Wong H. J Crit Care; 2013 Aug; 28(4):335-40. PubMed ID: 23337482 [Abstract] [Full Text] [Related]
11. The burden of Clostridium difficile in surgical patients in the United States. Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114 [Abstract] [Full Text] [Related]
20. Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy. Han XH, Du CX, Zhang CL, Zheng CL, Wang L, Li D, Feng Y, DuPont HL, Jiang ZD, Shi YK. Anaerobe; 2013 Dec; 24():82-4. PubMed ID: 23770543 [Abstract] [Full Text] [Related] Page: [Next] [New Search]